Chemists at the University of Göttingen develop resource-saving process
For the production of drugs, pesticides and smartphone displays, most of the processes are cost-intensive and generate a large amount of waste. Scientists at the University of Göttingen have now succeeded in developing a resource-saving “green” alternative. The results were published in Nature Catalysis.
The environmentally friendly strategy developed by Professor Lutz Ackermann and his team at the Institute of Organic and Biomolecular Chemistry at the University of Göttingen offers major advantages over existing methods. The naturally occurring non-toxic metal manganese is employed instead of noble transition metals such as palladium or platinum. Traditionally, organic solvents, which are highly flammable and toxic, were also used. In contrast, the new approach makes use of environmentally-friendly water. This is possible because a manganese-carbon bond is formed in the reaction. This bond is considerably more stable than comparable bonds between carbon and the highly reactive metals lithium or magnesium.
“The new process makes it possible to cleave a single strong carbon-carbon bond, of which organic compounds contain a large number, and convert it into the desired product,” says Ackermann. In order to achieve the results, experimental laboratory investigations were combined with computer-aided calculations. “This allowed us to gain detailed insight into the exact mode of action of the catalyst. And this in turn enables us to use the process to manufacture other materials.”
Learn more: The new green alternative for drug production
The Latest on: Drug production
[google_news title=”” keyword=”drug production” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Drug production
- Biocon inks supply, distribution pact with Medix for chronic weight management drug in Mexicoon May 12, 2024 at 9:54 pm
Under the agreement with Medix, a specialty pharmaceutical firm, Biocon will be responsible for obtaining regulatory approval, manufacturing and supply of the drug, the company said in a statement.
- Biocon inks pact with Medix to commercialize weight mgmt producton May 12, 2024 at 7:46 pm
Biocon said that it has signed semi-exclusive distribution and supply agreement with Medix for the commercialization of its vertically integrated drug product, Liraglutide (gSaxenda), used in the ...
- Mumbai cops bust drug factory in Rajasthan, drugs worth Rs 104 crores seizedon May 12, 2024 at 7:31 pm
Mumbai police seized drugs worth ₹104cr from a Rajasthan factory linked to a previous Mumbai bust. The investigation involved tracking suspects from M ...
- 1 arrested in drug bust near Hollywood apartment complexon May 10, 2024 at 6:36 pm
HOLLYWOOD, Calif. (KABC) -- One person was arrested Friday during a drug bust in Hollywood, authorities said. According to the Los Angeles Police Department, officers served a search warrant near an ...
- The Worsening Prescription Drug Shortage and How to Cope With Iton May 10, 2024 at 12:19 pm
The article The Worsening Prescription Drug Shortage and How to Cope With It originally appeared on NerdWallet.
- DEA skeptical cartels ordered stop to fentanyl productionon May 10, 2024 at 11:50 am
In early 2023, the leaders of the Sinaloa and Jalisco cartels reportedly ordered subordinates to stop the production of fentanyl.
- DEA Reports Fentanyl As “Nation’s Greatest Drug Threat”, THC Potency At All-Time Highon May 10, 2024 at 8:46 am
DEA Administrator Anne Milgram unveiled the 2024 National Drug Threat Assessment (NDTA), a comprehensive strategic analysis shedding light on illicit ...
- Drug shortages: What to do when you can’t get your medicineon May 9, 2024 at 8:00 pm
They’re among 128 drugs listed on the U.S. Food and Drug Administration’s drug shortage page this week as being currently in very short supply or having just had a shortage resolved.
- Why domestic U.S. production for lifesaving drugs is mandatory or innovation will die | Gueston May 9, 2024 at 8:50 am
Opinion: The BIOSECURE Act is a bill in Congress that aims to prevent Chinese manufacturers from accessing U.S. federal funding.
- Researchers target spermidine production to combat emerging drug resistance in Salmonellaon May 7, 2024 at 5:00 pm
They also find that an existing FDA-approved drug can reduce spermidine production, weakening the bacterium's ability to cause infection. When Salmonella infects a host, it is engulfed by ...
via Bing News